In 2025, SIA "Cosmetics NORD" had revenue of 5.1 million EUR and profit of 183.1 thousand EUR. The company has 23 employees. Beneficial owners: Lote Tisenkopfa-Iltnere, Uldis Iltners.
| year | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 5,1m € +90.6% | 2,7m € +32.2% | 2m € +69.9% |
Profit | 183,1k € +46.8% | 124,8k € +220.0% | -104k € +63.2% |
Assets | 2,6m € +51.9% | 1,7m € +13.3% | 1,5m € +27.4% |
Liabilities | 2,1m € +46.1% | 1,4m € -25.1% | 1,9m € +29.2% |
Equity | 524,5k € +80.0% | 291,3k € +176.0% | -383,5k € -37.2% |
Employees | 34 +41.7% | 24 +71.4% | 14 +16.7% |
Overall rating | A+100/100 |
Financial health | 100/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 100/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board chairman | Independently | ||||
| Board member | Independently | ||||
| Board member | Independently |
| Name | Changed |
|---|---|
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
| SIA "MADARA International" | 14 July 2014 |
| SIA "MADARA FOODS" | 22 October 2013 |
Project count
50
Total funding
€46 454 246
EU support
€30 375 000
| Project | Period | Role | Funding received | Status |
|---|---|---|---|---|
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts jaunu produktu un pakalpojumu ieviešanai uzņēmējdarbībā Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 2.2.1.3.i.0/1/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
2.2.1.3.i.0/1/24/A/CFLA/005 | - | partner | - | - |
SIA "Cosmetics NORD" is located at Mārupes nov., Mārupes pag., "Lielmaņi", LV-2167.
In 2025, SIA "Cosmetics NORD" had revenue of 5 116 716 EUR and profit of 183 138 EUR. Compared to previous year, revenue increased by 90.6%. View full financial report →
In 2024, SIA "Cosmetics NORD" had an average of 23 employees. View tax history →
The beneficial owners of SIA "Cosmetics NORD" are Lote Tisenkopfa-Iltnere and Uldis Iltners. View ownership details →
Yes, SIA "Cosmetics NORD" is registered as an active VAT payer with VAT number LV40103277805.
In 2024, the average gross salary at SIA "Cosmetics NORD" was approximately 1910,12 € per month (net ~ 1403,67 €). This is an approximate calculation. View salary details →
SIA "Cosmetics NORD" was founded on March 3, 2010. The company has been operating for 16 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 16 years | - | 0% | |
Net revenue | 5 116 716,00 € | - | 0% | |
Profit | 183 138,00 € | - | 0% | |
Equity | 524 473,00 € | - | 0% | |
Assets | 2 592 020,00 € | - | 0% | |
Fixed assets | 230 451,00 € | - | 0% | |
Investments | 2800,00 € | - | 0% | |
Liquidity | 1.02 | - | 25% | |
Profitability | 3.6% | - | 10% | |
Registered capital | 1 227 548,00 € | - | 0% |
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| SIA SLFNMD | 1 227 548 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Lote Tisenkopfa-Iltnere | LV | ||
| Uldis Iltners | LV |